Joaquin Mendoza
Overview
Explore the profile of Joaquin Mendoza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutierrez-Bautista J, Diaz-Alberola I, Tarrino M, Aguilera M, Cobo F, Reguera J, et al.
Clin Exp Immunol
. 2024 May;
217(3):253-262.
PMID: 38693777
The COVID-19 pandemic highlighted the importance of effective vaccination strategies in controlling the spread of infectious diseases. SARS-CoV-2 vaccine has demonstrated high efficacy in preventing COVID-19 infection in the general...
2.
Corma-Gomez A, Fernandez-Fuertes M, Vinuela L, Dominguez C, Santos M, Fuentes-Lopez A, et al.
J Med Virol
. 2023 Mar;
95(3):e28602.
PMID: 36880164
The aim of this study was to assess the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines among people living with HIV (PLWH) with severe immunosuppression, after a...
3.
Serrano-Conde E, Leyva A, Fuentes A, De Salazar A, Chueca N, Perez-Castro S, et al.
Transbound Emerg Dis
. 2021 Dec;
69(5):2649-2655.
PMID: 34910373
SARS-CoV-2 variation represents a serious challenge to current COVID-19 vaccines. Recent reports suggest that B.1.351 and other variants may escape the neutralization activity of the antibodies generated by current vaccines....
4.
Nguyen D, Simmonds P, Steenhuis M, Wouters E, Desmecht D, Garigliany M, et al.
Euro Surveill
. 2021 Jul;
26(27).
PMID: 34240697
We compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma...
5.
Gimenez L, Rojas J, Rojas A, Mendoza J, Camacho A
Clin Vaccine Immunol
. 2008 Nov;
16(2):241-5.
PMID: 19038782
A new enzyme-linked immunosorbent assay (ELISA)-based immunoglobulin G (IgG)-plus-IgM antibody detection test for severe acute respiratory syndrome (SARS) has been developed by using a cocktail of four recombinant polypeptides as...
6.
Rojas A, Rojas J, Mendoza J
Clin Vaccine Immunol
. 2007 Feb;
14(2):208.
PMID: 17284648
No abstract available.
7.
Lain A, Moragues M, Garcia Ruiz J, Mendoza J, Camacho A, Del Palacio A, et al.
Clin Vaccine Immunol
. 2007 Jan;
14(3):318-9.
PMID: 17229884
The performance of a new test to detect antibodies to Candida albicans recombinant enolase was investigated in 47 immunocompromised and 51 immunocompetent patients. The sensitivity, specificity, and positive and negative...
8.
Gutierrez J, Linares J, Fernandez F, Ros E, Luna J, Mendoza J, et al.
Med Clin (Barc)
. 2004 Nov;
123(15):561-6.
PMID: 15535936
Background And Objective: The relationship between peripheral arterial occlusive disease (PAOD) and Chlamydophila pneumoniae infection was studied by analyzing clinical samples from 95 patients with PAOD (cases) and 100 controls....
9.
Moragues M, Ortiz N, Iruretagoyena J, Garcia-Ruiz J, Amutio E, Rojas A, et al.
Enferm Infecc Microbiol Clin
. 2004 Feb;
22(2):83-8.
PMID: 14756989
Introduction: Two tests for the detection of antibodies to Candida albicans germ tubes in patients with invasive candidiasis were compared: a new commercially available test (Candida albicans IFA IgG) and...